Body weight and mortality in COPD: focus on the obesity paradox
- 487 Downloads
The positive association between overweight, obesity, and cardiovascular and all-cause mortality is well established, even though this relation is typically U shaped with an increased risk also in low-weight subjects. However, being overweight or obese has been associated with a better prognosis in subjects suffering from chronic diseases, id est the “obesity paradox”. In both community-dwelling and hospitalized patients with COPD, several studies have reported a significant protective effect of obesity on all-cause mortality, indicating that also in obstructive pulmonary diseases, an obesity paradox may be present. Interestingly, the “paradox” is more evident for subjects with severe bronchial obstruction (i.e., a lower FEV1), while in mild–moderate conditions, the weight-related mortality shows a behavior similar to that observed in the general population. Several factors may confound the relation between COPD, obesity and mortality. The lower FEV1 found in obese people may be linked to a restrictive defect rather than to an obstructive one. Due to the modified chest wall mechanical properties—related to increased fat mass—obese COPD patients may present, respect to their lean counterpart, a lower lung hyperinflation which is associated with higher mortality. The traditional classification of COPD attributes to obese “blue bloaters” a low-grade emphysema in opposition to lean “pink puffers”; the fact that emphysema extent is related to mortality may bias the relationship between weight and survival. It is also to underline that the majority of the studies, consider BMI rather than body composition (a better predictor of mortality) when studying the intriguing relation between weight, COPD, and mortality. Reverse bias has also to be taken into account, hypothesizing that an unintentional weight loss may be the deleterious factor related to mortality, rather than considering obesity a protective one. Further prospective studies are needed to shed light on the complexity of this emerging issue.
Level of evidence
Level V: Narrative Review.
KeywordsOverweight Obesity Visceral obesity Obesity paradox Pulmonary function COPD
Compliance with ethical standards
Conflict of interest
The authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest in the subject matter or materials discussed in this manuscript.
This article does not contain any studies with human participants or animals performed by any of the authors.
For this type of study formal consent is not required.
- 7.Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J Jr (2002) The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 39(4):578–584. doi: 10.1016/S0735-1097(01)01802-2 CrossRefPubMedGoogle Scholar
- 15.Vernooy JH, Kucukaycan M, Jacobs JA et al (2002) Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 166(9):1218–1224. doi: 10.1164/rccm.2202023 CrossRefPubMedGoogle Scholar
- 16.Fratta Pasini AM, Ferrari M, Stranieri C, Vallerio P, Mozzini C, Garbin U, Zambon G, Cominacini L (2016) Nrf2 expression is increased in peripheral blood mononuclear cells derived from mild–moderate ex-smoker COPD patients with persistent oxidative stress. Int J Chron Obstruct Pulmon Dis 11:1733–1743. doi: 10.2147/COPD.S102218 CrossRefPubMedPubMedCentralGoogle Scholar
- 22.International Diabetes Federation. Metabolic syndrome. The IDF consensus worldwide definition of the metabolic syndrome. http://www.idf.org. Accessed March 2017
- 23.Cebron Lipovec N, Beijers RJ, van den Borst B, Doehner W, Lainscak M, Schols AM (2016) The prevalence of metabolic syndrome in chronic obstructive pulmonary disease: a systematic review. COPD 13:399–406. doi: 10.3109/15412555.2016.1140732
- 44.Zapatero A, Barba R, Ruiz J et al (2013). Malnutrition and obesity: influence in mortality and readmissions in chronic obstructive pulmonary disease patients. J Hum Nutr Diet 26 Suppl 1:16–22 doi: 10.1111/jhn.12088
- 46.Divo MJ, Cabrera C, Casanova C, Marin JM, Pinto-Plata VM, de-Torres JP, Zulueta J, Zagaceta J, Sanchez-Salcedo P, Berto J, Cote C, Celli BR (2014) Comorbidity distribution, clinical expression and survival in COPD patients with different body mass index. Chronic Obstr Pulm Dis 1(2):229–238 8. doi: 10.15326/jcopdf.1.2.2014.0117 CrossRefPubMedPubMedCentralGoogle Scholar
- 47.Yamauchi Y, Hasegawa W, Yasunaga H, Sunohara M, Jo T, Takami K, Matsui H, Fushimi K, Nagase T (2014) Paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in Japan. Int J Chron Obstruct Pulmon Dis 9:1337–1346. doi: 10.2147/COPD.S75175 CrossRefPubMedPubMedCentralGoogle Scholar
- 62.Zulueta JJ, Wisnivesky JP, Henschke CI, Yip R, Farooqi AO, McCauley DI, Chen M, Libby DM, Smit JP, Pasmantier MW, Yankelevitz DV (2012) Emphysema scores predict death from COPD and lung cancer. 141(5):1216–1223 doi: 10.1378/chest.11-0101
- 63.Oelsner EC, Carr JJ, Enright PL, Hoffman EA, Folsom AR, Kawut SM, Kronmal RA, Lederer DJ, Lima JAC, Lovasi GS, Smith BM, Shea S, Graham Barr R (2016) Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study. Thorax 71:624–632. doi: 10.1136/thoraxjnl-2015-207822 CrossRefPubMedPubMedCentralGoogle Scholar